Walleye Capital LLC Evolus, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 29,700 shares of EOLS stock, worth $433,323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,700
Previous 212,209
86.0%
Holding current value
$433,323
Previous $3.44 Million
90.49%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$75.1 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$72.9 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$58.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$46.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$45.7 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $818M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...